Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-19T23:39:37.836Z Has data issue: false hasContentIssue false

Facial Protective Equipment, Personnel, and Pandemics: Impact of the Pandemic (H1N1) 2009 Virus on Personnel and Use of Facial Protective Equipment

Published online by Cambridge University Press:  02 January 2015

Melanie Murray
Affiliation:
Department of Internal Medicine, Division of Infectious Disease, Vancouver, British Columbia, Canada
Jennifer Grant
Affiliation:
Department of Pathology and Laboratory Medicine, Division of Medical Microbiology and Infection Control, University of British Columbia, Vancouver, British Columbia, Canada
Elizabeth Bryce*
Affiliation:
Department of Pathology and Laboratory Medicine, Division of Medical Microbiology and Infection Control, University of British Columbia, Vancouver, British Columbia, Canada
Paul Chilton
Affiliation:
Warehouse and Logistics, BC Health Authorities Shared Services Organization, Vancouver, British Columbia, Canada
Leslie Forrester
Affiliation:
Department of Pathology and Laboratory Medicine, Division of Medical Microbiology and Infection Control, University of British Columbia, Vancouver, British Columbia, Canada
*
Department of Pathology and Laboratory Medicine, Division of Medical Microbiology and Infection Control, University of British Columbia, Vancouver General Hospital, JPN 111 (Microbiology), 855 West 12th Avenue, Vancouver, BC V5Z 1M9, Canada (Elizabeth.Bryce@vch.ca)

Extract

Background.

Before the emergence of the pandemic (H1N1) 2009 virus, estimates of the stockpiles of facial protective equipment (FPE) and the impact that information had on personnel during a pandemic varied.

Objective.

To describe the impact of H1N1 on FPE use and hospital employee absenteeism.

Setting.

One tertiary care hospital and 2 community hospitals in the Vancouver Coastal Health (VCH) region, Vancouver, Canada.

Patients.

All persons with influenza-like illness admitted to the 3 VCH facilities during the period from June 28 through December 19, 2009.

Methods.

Data on patients and on FPE use were recorded prospectively. Data on salaried employee absenteeism were recorded during the period from August 1 through December 19, 2009.

Results.

During the study period, 865 patients with influenza-like illness were admitted to the 3 VCH facilities. Of these patients, 149 (17.2%) had laboratory-confirmed H1N1 influenza infection. The mean duration of hospital stay for these patients was 8.9 days, and the mean duration of intensive care unit stay was 9.2 days. A total of 134,281 masks and 173,145 N95 respirators (hereafter referred to as respirators) were used during the 24-week epidemic, double the weekly use of both items, compared with the previous influenza season. A ratio of 3 masks to 4 respirators was observed. Use of disposable eyewear doubled. Absenteeism mirrored the community epidemiologic curve, with a 260% increase in sick calls at the epidemic peak, compared with the nadir.

Conclusion.

Overall, FPE use more than doubled, compared with the previous influenza season, with respirator use exceeding literature estimates. A significant proportion of FPE resources were used while managing suspected cases. Planners should prepare for at least a doubling in mask and respirator use, and a 3.6-fold increase in staff sick calls.

Type
Original Articles
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Ninove, L, Gazin, C, Gould, EA, et al.A simple method for molecular detection of swine-origin and human-origin influenza A virus. Vector Borne Zoonotic Dis 2010;10(3):237240.CrossRefGoogle ScholarPubMed
2.Pabbaraju, K, Wong, S, Wong, AA, et al.Design and validation of realtime reverse transcription-PCR assays for detection of pandemic (H1N1) 2009 virus. J Clin Microbiol 2009;47(11):34543460.Google Scholar
3.Vasoo, S, Stevens, J, Singh, K. Rapid antigen tests for diagnosis of pandemic (swine) influenza A/H1N1. Clin Infect Dis 2009;49(7):10901093.CrossRefGoogle ScholarPubMed
4.Centers for Disease Control and Prevention (CDC). Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemie influenza A (H1N1)—United States, May-June 2009. MMWR Morb Mortai Wkly Rep 2009;58(44):12411245.Google Scholar
5.Eisen, DP, McBryde, ES. Avoiding Guillan-Barré syndrome following swine origin pandemic H1N1 2009 influenza vaccination. J Infect Dis 2009;20(110):16271628.CrossRefGoogle Scholar
6.Tuite, AR, Greer, AL, Whelan, M, et al.Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza. CMAJ 2010;182(2):131136.Google Scholar
7.Calatayud, L, Kurkela, S, Neave, PE, et al.Pandemic (H1N1) 2009 virus outbreak in a school in London, April-May 2009: an observational study. Epidemiol Infect 2010;138(2):183191.CrossRefGoogle Scholar
8.Kumar, A, Zarychanski, R, Pinto, R, et al.Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009;302(17):18721879.Google Scholar
9.Rello, J, Rodriguez, A, Ibanez, P, et al.Intensive care adult patients with severe respiratory failure caused by influenza A (H1N1)v in Spain. Crif Care 2009;13(5):R148.Google Scholar
10.Webb, SA, Pettila, V, Seppelt, I, et al.Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009;61(20):19251934.Google Scholar
11.New South Wales public health network. Progression and impact of the first winter wave of the 2009 pandemic H1N1 influenza in New South Wales, Australia. Euro Surveill 2009;14(42). pii: 19365.Google Scholar
12.Fouchier, RA, Bestebroer, TM, Herfst, S, Van Der Kemp, L, Rimmelzwaan, GF, Osterhaus, AD. Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene. J Clin Microbiol 2000;38(11):40964101.Google Scholar
13. Public Health Agency of Canada. Guidance: infection prevention and control measures for health care workers in acute care facilities. 28 July 2009. http://www.phac-aspc.gc.ca/alert-alerte/hlnl/hp-ps/ig_acf-ld_esa -eng.php. Accessed 15 March 2010.Google Scholar
14.Lum, ME, McMillan, AJ, Brook, CW, Lester, R, Piers, LS. Impact of pandemic (H1N1) 2009 influenza on critical care capacity in Victoria. Med J Aust 2009;191(9):502506.Google Scholar
15.Influenza A(H1N1)v investigation teams; Levy-Bruhl, D, Vaux, S. Modified surveillance of influenza A(H1N1)v virus infections in France. Euro Surveill 2009;14(29). pii: 19276.Google Scholar
16. World Health Organization (WHO). Infection prevention and control of epidemic- and pandemic-prone acute respiratory diseases in health care. WHO interim guidelines. June 2007. http://www.who.int/csr/resources/publications/WHO_CDS_EPR_2007_6c.pdf. Accessed 15 March 2010.Google Scholar
17. US Department of Labor. Occupational Safety and Health Administration (OSHA). Proposed guidance on workplace stockpiling of respirators and facemasks for pandemic influenza, http://www.osha.gov/dsg/guidance/proposedGuidanceStockpilingRespirator.pdf. Accessed 15 March 2010.Google Scholar
18.Fielding, J, Higgins, N, Gregory, J, et a1Pandemic HINl influenza surveillance in Victoria, Australia, April-September, 2009. Euro Surveill 2009;14(42). pii: 19368.Google Scholar
19.Jain, S, Kamimoto, L, Bramley, AM, et al.Hospitalized patients with 2009 HINl influenza in the United States, April-June 2009. N Engl J Med 2009;361(20):19351944.Google Scholar
20. Public Health Agency of Canada (PHAC). Canada Communicable Disease Report (CCDR). Guidelines for preventing the transmission of tuberculosis in Canadian health care facilities and other institutional settings. Vol. 22S1. April 1996. http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/96vol22/22sl/. Accessed 11 August 2010.Google Scholar
21.Siow, S, Bryce, EA, Scharf, S. Health care workers' perceptions of respiratory and gastrointestinal algorithms for patient management in emergency care settings. Am J Infect Control 2009;37(9):759765.Google Scholar
22. US Department of Labor. Occupational Safety and Health Administration (OSHA). Pandemic influenza preparedness and response guidance for healthcare workers and healthcare employers. Document OSHA 3328-05R 2009. http://www.osha.gov/Publications/OSHA_pandemic_health.pdf. Accessed 15 March 2010.Google Scholar
23.Kuehn, BM. CDC updates recommendations for protecting clinicians from influenza. JAMA 2009;302(17):1847.CrossRefGoogle ScholarPubMed
24. National Health Service (NHS). HPIH8eSDPIP. Pandemic (HINl) 2009 influenza: a summary of guidance for infection control in healthcare settings. December 2009. http://www.dh.gov.uk/prod_consum_dh/groups/dh _digitalassets/@dh/@en/@ps/documents/digitalasset/dh_110899.pdf. Accessed 15 March 2010.Google Scholar